Covered recipient · General Payments record
BLAIZIE B GOVEAS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$6,495.71
- Reported across 238 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $880.50 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $338.97 | 24 |
| Abbott Laboratories | $312.79 | 8 |
| Philips Electronics North America Corporation | $112.91 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $79.04 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.37 | 1 |
| PFIZER INC. | $16.42 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $5.96 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201826 | CMS |
| Abbott Laboratories | $1.29 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201828 | CMS |
| Abbott Laboratories | $121.02 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201830 | CMS |
| Abbott Laboratories | $25.70 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201832 | CMS |
| Abbott Laboratories | $33.80 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201834 | CMS |
| Abbott Laboratories | $23.45 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201836 | CMS |
| Abbott Laboratories | $23.77 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201838 | CMS |
| Abbott Laboratories | $77.80 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125201840 | CMS |
| Amgen Inc. | $10.79 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674284 | CMS |
| Amgen Inc. | $8.61 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674292 | CMS |
| Amgen Inc. | $16.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674305 | CMS |
| Amgen Inc. | $7.27 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674315 | CMS |
| Amgen Inc. | $20.29 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674323 | CMS |
| Amgen Inc. | $27.03 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674329 | CMS |
| Amgen Inc. | $8.89 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674338 | CMS |
| Amgen Inc. | $14.53 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674190 | CMS |
| Amgen Inc. | $16.69 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674201 | CMS |
| Amgen Inc. | $21.53 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674209 | CMS |
| Amgen Inc. | $9.70 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674218 | CMS |
| Amgen Inc. | $8.03 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674267 | CMS |
| Amgen Inc. | $10.98 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674276 | CMS |
| Amgen Inc. | $16.27 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674182 | CMS |
| Amgen Inc. | $17.00 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674236 | CMS |
| Amgen Inc. | $15.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674227 | CMS |
| Amgen Inc. | $17.90 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117566050 | CMS |
| Amgen Inc. | $23.30 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674244 | CMS |
| Amgen Inc. | $6.71 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117566052 | CMS |
| Amgen Inc. | $9.20 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674253 | CMS |
| Amgen Inc. | $7.34 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117566054 | CMS |
| Amgen Inc. | $22.55 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117566056 | CMS |
| Amgen Inc. | $9.48 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117566058 | CMS |
| Amgen Inc. | $12.63 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115674260 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.37 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118114003 | CMS |
| Novartis Pharmaceuticals Corporation | $23.44 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086787661 | CMS |
| Novartis Pharmaceuticals Corporation | $20.59 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086787667 | CMS |
| Novartis Pharmaceuticals Corporation | $35.01 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086787679 | CMS |
| PFIZER INC. | $16.42 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131455465 | CMS |
| Philips North America LLC | $112.91 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146901032 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.